Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.
Keywords: interferon beta‐1b; morphea; multiple sclerosis.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.